Company Overview of MaxCyte, Inc.
Key Executives for MaxCyte, Inc.
|Douglas Arthur Doerfler||120 Relationships||Co-Founder, Chief Executive Officer, President, Director and Member of Nominations Committee||60|
|Ronald Evan Holtz CPA||6 Relationships||Chief Financial Officer, Secretary and Director||58|
|Madhusudan Viswanath Peshwa Ph.D.||1 Relationships||Chief Scientific Officer and Executive Vice President of Cellular Therapies||48|
MaxCyte, Inc. Board Members*
|Name||Board Relationships||Primary Company||Age|
|J. Stark Thompson Ph.D.||12 Relationships||Ore Holdings, Inc||74|
|Douglas Arthur Doerfler||120 Relationships||MaxCyte, Inc.||60|
|Ronald Evan Holtz CPA||6 Relationships||MaxCyte, Inc.||58|
|William W. Brooke J.D.||31 Relationships||Wallace, Jordan, Ratcliff & Brandt||59|
|Arthur Michael Mandell||23 Relationships||Prestwick Pharmaceuticals, Inc.||63|
MaxCyte, Inc. Executive Committees*
|Committee Name||Chairperson||Board Relationships||Members|
|Audit Committee J.D.||William W. Brooke||31 Relationships||2 Executives|
|Compensation Committee Ph.D.||J. Stark Thompson||12 Relationships||3 Executives|
|Nominating Committee||Arthur Michael Mandell||23 Relationships||3 Executives|
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.
CEO COMPENSATION IN THIS INDUSTRY
|Total Short Term Compensation|
|Total Value of Options|
INDUSTRY EXECUTIVE CHANGES
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.